Clinical Trials Directory

Trials / Completed

CompletedNCT04174092

Catastrophism in Chronic Inflammatory Rheumatism

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
533 (actual)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Catastrophic is defined as a negative cognitive and emotional response based on inadequate pain expression. It has three components: rumination, amplification and vulnerability. The assessment of catastrophism is carried out using a validated questionnaire called the "Pain Catatrophizing Scale" (PCS). Recent studies highlight the significant impact of catastrophism in neuromuscular and mechanical rheumatic diseases such as gonarthrosis gonalgia and low back pain. In these diseases, it has been shown that catastrophism has a negative impact both on the experience of pain and on the response to different types of treatments (medical and surgical). Several studies have implemented multidisciplinary management and in particular cognitive-behavioural therapy with an improvement in the pain experience in patients who are catastrophic. In chronic inflammatory rheumatic diseases such as rheumatoid arthritis, spondyloarthritis and psoriatic arthritis, the prevalence and impact of catastrophism is still poorly understood.

Conditions

Interventions

TypeNameDescription
OTHERcompleting self-questionnairescompleting self-questionnaires on quality of life, anxiety, insomnia, activity of rheumatic disease and catastrophism

Timeline

Start date
2019-10-27
Primary completion
2022-12-17
Completion
2022-12-17
First posted
2019-11-22
Last updated
2023-03-21

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04174092. Inclusion in this directory is not an endorsement.